Through the barricades: overcoming the barriers to effective antibody-based cancer therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Through the barricades: overcoming the barriers to effective antibody-based cancer therapeutics

Published:2018-06-12 Issue:9 Volume:28 Page:697-712
ISSN:1460-2423
Container-title:Glycobiology
language:en
Short-container-title:

Author:

Dalziel Martin¹,Beers Stephen A²,Cragg Mark S²,Crispin Max³⁴^ORCID

Affiliation:

1. Oxford Glycobiology Institute, Department of Biochemistry, South Parks Road, Oxford, UK

2. Antibody & Vaccine Group, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK

3. Centre for Biological Sciences, University of Southampton, Southampton, UK

4. Institute for Life Sciences, Highfield Campus, University of Southampton, Southampton, UK

Publisher

Oxford University Press (OUP)

Subject

Biochemistry

Link

http://academic.oup.com/glycob/article-pdf/28/9/697/25510583/cwy043.pdf

Reference189 articles.

1. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules;Adams;Cancer Res,2001

2. Site-specific antibody-drug conjugates: The nexus of bioorthogonal chemistry, protein engineering, and drug development;Agarwal;Bioconjug Chem,2015

3. Trastuzumab biosimilar on track for approval;American Association for Cancer Research;Cancer Discov,2017

4. Biosimilars versus ‘biobetters’—a regulator’s perspective;Anour;GaBI J,2014

5. Identification of a receptor required for the anti-inflammatory activity of IVIG;Anthony;Proc Natl Acad Sci U S A,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer;Molecular Therapy - Nucleic Acids;2023-12

2. Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation;Biochimica et Biophysica Acta (BBA) - General Subjects;2023-11

3. Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody;Frontiers in Immunology;2022-08-31

4. Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics;mAbs;2021-01-01

5. Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering;Antibodies;2020-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3